Cancer treatment hospital room.
Cancer treatment hospital room.

HDFC Asset Management Company, which oversees HDFC Mutual Fund, is introducing the fifth installment of its Cancer Cure initiative through the HDFC Charity Fund for Cancer Cure. This program lets investors allocate part of their dividend income, generated via the IDCW option, to help underprivileged cancer patients.

The new fund offering begins enrollment on November 16, 2026, and remains open until November 30, 2026. Data from ICMR-NCDIR indicates India recorded 14,61,427 new cancer cases in 2022, a diagnosis occurring roughly every 22 seconds.

Since its 2011 launch, the Cancer Cure series has generated ₹292.41 crore for the Indian Cancer Society, including direct contributions from HDFC AMC. Of this total, ₹273.28 crore has been allocated to treating 17,435 patients across 22 medical facilities. Remarkably, nearly one in four beneficiaries was a child aged 15 or younger.

Participants can designate 50% or 75% of their IDCW payouts to the Indian Cancer Society, with HDFC AMC matching donations up to ₹16 crore annually. The original investment sum is returned to contributors upon maturity.

To maximize impact, HDFC AMC has eliminated its investment management and advisory fees, ensuring a larger portion of funds benefits the cause.

Usha Thorat of the Indian Cancer Society noted that the initiative’s support has provided financial aid to over 17,000 patients across 22 hospitals.

The Cancer Cure series has united investors, financial institutions, and the Indian Cancer Society to combat a disease affecting millions. With its fifth edition now active, the program aims to expand its reach, encouraging broader participation in a mission where every contribution delivers tangible support.